| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Revenues | 16,965,658 | |||
| Cost of revenues | 9,595,152 | |||
| Gross profit | 7,370,506 | |||
| Research and development | 386,565 | |||
| General and administrative | 7,626,342 | |||
| Total operating expenses | 8,012,907 | |||
| Operating (loss)/income | -642,401 | |||
| Other income/(expense), net | 68,002 | |||
| Interest expense | 461,504 | |||
| Changes in fair value of warrant liability | 3,615,437 | |||
| Gain/(loss) on exercise of warrant liabilities | 74,008 | |||
| Total other income/(expense), net | -3,934,931 | |||
| Net loss before income taxes | -4,577,332 | |||
| Income tax expense | 14,035 | |||
| Loss from continuing operations | -4,591,367 | |||
| (loss)/income from discontinued operations, net of tax | -42,280 | |||
| Net loss | -4,633,647 | |||
| Less net loss in noncontrolling interest | -90,312 | |||
| Net loss attributable to cemtrex, inc. stockholders | -4,543,335 | |||
| Weighted average number of shares - basic | 2,542,677 | |||
| Weighted average number of shares - diluted | 2,542,677 | |||
CEMTREX INC (CETXP)
CEMTREX INC (CETXP)